Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFOTAXIME Cause Incorrect product administration duration? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Incorrect product administration duration have been filed in association with CEFOTAXIME (Cefotaxime). This represents 0.2% of all adverse event reports for CEFOTAXIME.

5
Reports of Incorrect product administration duration with CEFOTAXIME
0.2%
of all CEFOTAXIME reports
0
Deaths
3
Hospitalizations

How Dangerous Is Incorrect product administration duration From CEFOTAXIME?

Of the 5 reports, 3 (60.0%) required hospitalization.

Is Incorrect product administration duration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFOTAXIME. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does CEFOTAXIME Cause?

Drug reaction with eosinophilia and systemic symptoms (276) Drug ineffective (242) Pyrexia (211) Off label use (182) Acute kidney injury (170) Rash maculo-papular (151) Toxic epidermal necrolysis (151) Rash (125) Hepatocellular injury (122) Eosinophilia (121)

What Other Drugs Cause Incorrect product administration duration?

ETONOGESTREL (3,974) POLYETHYLENE GLYCOL 3350 (2,129) NIRMATRELVIR\RITONAVIR (744) DOCOSANOL (634) LANSOPRAZOLE (564) LOPERAMIDE (543) NAPROXEN (499) INSULIN LISPRO (479) DICLOFENAC (362) OMEPRAZOLE (302)

Which CEFOTAXIME Alternatives Have Lower Incorrect product administration duration Risk?

CEFOTAXIME vs CEFOXITIN CEFOTAXIME vs CEFPODOXIME CEFOTAXIME vs CEFPODOXIME PROXETIL CEFOTAXIME vs CEFPROZIL CEFOTAXIME vs CEFTAROLINE

Related Pages

CEFOTAXIME Full Profile All Incorrect product administration duration Reports All Drugs Causing Incorrect product administration duration CEFOTAXIME Demographics